All News

Patients who received the shingles vaccine before treatment for arthritis with tofacitinib showed robust immune responses.

The degree of the success for HIV remission vary in different parts of the country.

Live varicella-zoster vaccine is adequately immunogenic in patients with rheumatoid arthritis starting treatment with tofacitinib.

The live varicella-zoster vaccine is adequately immunogenic in patients with rheumatoid arthritis starting treatment with tofacitinib, according to results of a recently-published study in Arthritis & Rheumatology.

Dr. David Singer discusses why he pursued the fellowship at Thomas Jefferson University in the College of Population Health and Janssen Scientific Affairs, LLC.

Insights into possible treatments for disorders that range from demyelination to plaque formation and misfolded proteins.

Find out what you have to do and work hard until you get it.

Up to 1.3 million women may not be receiving genetic testing to detect BRCA 1/2 mutations, which increase the risk of certain cancer types.

Top articles of the week from The American Journal of Pharmacy Benefits.

FDA officials noted that the human insulin analog met all necessary regulatory requirements for approval, but the approval is tentative pending any patent issues that are yet to be resolved.

Cladribine tablets demonstrated sustained clinical efficacy for up to 4 years treating multiple sclerosis.

Novel technology could reduce the number of unnecessary biopsies, ultimately reducing health care costs.

Houston-based specialty pharmacy takes extraordinary measures to demonstrate commitment to their patients during Hurricane Harvey.

PCSK9 inhibitors alter dendritic cells and T cells to reduce atherosclerosis.

JDRF and IBM partner to develop data-driven methods to predict the onset of type 1 diabetes.

Newly launched mobile research study uses real-time data collection in MS.

Self-administered acupressure found to improve sleep and daytime alertness among breast cancer survivors.

Top news of the day from across the healthcare landscape.

Top news of the day from across the healthcare landscape.

A look at the top stories in pharmacy last week.

A look at the top stories in pharmacy last week.

Hospira recalls vancomycin hydrochloride injection due to particulate matter contamination.

Clinical trial holds were placed on pembrolizumab to treat multiple myeloma following adverse event concerns.

Pembrolizumab (Keytruda) combination therapy may increase mortality risk among multiple myeloma patients.

Top articles of the week from Specialty Pharmacy Times.

Patients with psychological and substance use problems are less likely to stay engaged in hepatitis C care.

Human papillomavirus vaccine rates are on the rise among US teens but more work is needed.

This initiative emphasizes the importance of early recognition and timely treatment of sepsis, as well as the importance of preventing infections that could lead to sepsis.

Human papillomavirus (HPV) vaccine rates are on the rise among US teens but more work is needed to get more teens vaccinated.